STTK
Shattuck Labs, Inc. Health Care Pharmaceutical Preparations Russell 3000
$5.56Close
$351.8MMarket cap
$1.84 – $8.0652-week range
Nov 5, 2026Next report
Highlights
Strengths
- Leading the market RS 87 · stronger than 87% of stocks over 12 months
Cautions
- Not in an uptrend 4 of 8 trend conditions
- Far from its high 31% below its 52-week high
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
31%
1wk
up 1.3%
price change
1mo
down 18.5%
price change
12-month return
up 190%
market up 11% ·
its own up 174%
F-score
—
— Not assessed
Altman Z
16.96
Low risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
4.3×
price / book
Earnings yield
down 17.3%
EBIT / enterprise value
Cheaper than
17%
of the market · expensive
Revenue growth
down 83%
year on year
EPS growth
—
latest quarter
Sales growth
—
latest quarter
ROE
down 60%
return on equity
Free cash margin
down 3995%
-$40.0M FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
7.0%
$0.39 a day · 2×ATR $4.78
RS
87 / 99
vs the universe
Trend
4 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
1.24
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 4 of 8
- Price above the 150 and 200-day averages: fails
- 150-day average above the 200-day: passes
- 200-day average rising for a month: passes
- 50-day average above the 150 and 200-day: fails
- Price above the 50-day average: fails
- At least 30% above the 52-week low: passes
- Within 25% of the 52-week high: fails
- RS rank 70 or higher: passes
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 32.6% over the year, from 48m to 63m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
- Revenue shrinking Revenue fell 82.5% over the year, from $5.7M to $1.0M.
Last reported
Aug 11, 2026
Results reaction
Aug 11, 2026+5% vs market2 sessions after results
Financials
- Net -4881%
- Free cash -3995%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9M | $30.0M | $652,000 | $1.7M | $5.7M | $1.0M |
| Operating income | -$36.9M | -$45.3M | -$103.3M | -$92.0M | -$80.6M | -$51.5M |
| Net income | -$36.6M | -$45.0M | -$101.9M | -$87.3M | -$75.4M | -$48.8M |
| Net margin | -368% | -150% | -15636% | -5268% | -1318% | -4881% |
| Earnings per share | -$2.36 | -$1.07 | -$2.41 | -$2.05 | -$1.49 | -$0.70 |
| Free cash flow | -$34.4M | -$65.0M | -$106.1M | -$81.6M | -$60.6M | -$40.0M |
| Free cash margin | -346% | -217% | -16275% | -4927% | -1059% | -3995% |
| Cash | $157.9M | $92.3M | $47.4M | $125.6M | $57.4M | $54.2M |
| Shareholders' equity | $309.9M | $271.8M | $176.2M | $144.7M | $79.6M | $82.4M |
| Shares outstanding | 41.77m | 42.34m | 42.39m | 47.26m | 47.71m | 63.28m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 11, 2026 | Quarterly ↗ | Jun 30, 2026 | 42d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Mar 5, 2026 | Annual ↗ | Dec 31, 2025 | 64d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Aug 14, 2025 | Quarterly ↗ | Jun 30, 2025 | 45d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Mar 27, 2025 | Annual ↗ | Dec 31, 2024 | 86d |
| Nov 14, 2024 | Quarterly ↗ | Sep 30, 2024 | 45d |
| Aug 1, 2024 | Quarterly ↗ | Jun 30, 2024 | 32d |
| May 2, 2024 | Quarterly ↗ | Mar 31, 2024 | 32d |
| Feb 29, 2024 | Annual ↗ | Dec 31, 2023 | 60d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 11, 2026 | Results ↗ |
| Jun 11, 2026 | Material agreement ↗ |
| Jun 9, 2026 | Regulation FD · Other events ↗ |
| Jun 2, 2026 | Director or officer change · Shareholder vote ↗ |
| May 7, 2026 | Results ↗ |
| Mar 5, 2026 | Results ↗ |
| Feb 5, 2026 | Other events ↗ |
| Jan 22, 2026 | Material agreement ↗ |
| Nov 6, 2025 | Results ↗ |
| Aug 26, 2025 | Director or officer change · Regulation FD ↗ |
| Aug 14, 2025 | Results ↗ |
| Aug 5, 2025 | Material agreement · Unregistered share sale · Regulation FD ↗ |